...
首页> 外文期刊>International Journal of Cardiology >Quantification of circulating CD34+/KDR+/CD45 dim endothelial progenitor cells: Analytical considerations
【24h】

Quantification of circulating CD34+/KDR+/CD45 dim endothelial progenitor cells: Analytical considerations

机译:循环中的CD34 + / KDR + / CD45朦胧内皮祖细胞的定量分析

获取原文
获取原文并翻译 | 示例

摘要

The discovery of peripheral circulating cells that contribute to vasculogenesis and endothelial repair was one of the most fascinating breakthroughs in the domain of vascular research during the last two decades. The population of vasculogenic cells however, is heterogeneous and can be analyzed using different approaches including in vitro culture and flow cytometry. Circulating CD34+/KDR+/CD45dim endothelial progenitor cells (EPC) have a great potential as biomarkers in various cardiovascular diseases. With the expanding interest in this field, the development of standardized protocols is critical. In this review we describe in detail the pre-analytical and analytical factors that should be taken into account when quantifying CD34+/KDR+/CD45dim EPC using flow cytometry. Moreover, technical suggestions in order to enhance accuracy and reproducibility of this enumeration are provided.
机译:在过去的二十年中,发现有助于血管生成和内皮修复的外周循环细胞是血管研究领域最引人注目的突破之一。但是,血管生成细胞的群体是异质的,可以使用不同的方法进行分析,包括体外培养和流式细胞仪。循环中的CD34 + / KDR + / CD45dim内皮祖细胞(EPC)作为多种心血管疾病的生物标志物具有巨大潜力。随着对该领域的兴趣不断扩大,标准化协议的开发至关重要。在这篇综述中,我们详细描述了使用流式细胞仪定量CD34 + / KDR + / CD45dim EPC时应考虑的分析前和分析因素。此外,提供了用于提高该枚举的准确性和可重复性的技术建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号